Pharma & Bio

Latest Content

Industry applauds Autumn Statement support but seeks coherent plan 

Manufacturing and process industry chiefs have welcomed in principle the commitments made by Chancellor Jeremy Hunt in his Autumn Statement aimed at science-led economic growth but have pushed for si…

Editor's comment

'Interesting times' beckon for pharma and biotech

The scale of pharmaceutical counterfeiting can be staggering to behold – whether in terms of the number of cases, the financial incentives or the economic loss to the legitimate industry.

Comment & Features

Industry can solve a major health problem by not taking a stand

Is it time to revisit the laws on time being spent on our feet during active work hours, wonders Will Munro, given that musculoskeletal disorders account for nearly half of all work-related ill healt…